Balaji Venkataraman insider trades: Jasper Therapeutics (JSPR) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Balaji reports to the SEC
Open-market buys and sales
5 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Feb 8, 2024 | JSPR | ↑ Buy | 350,000 | $12.95 | $4.5M | By Velan Capital Master Fund LP | Feb 9, 2024 (1d) |
| Sep 9, 2019 | PGNX | ↑ Buy | 72,023 | $4.99 | $360K | Direct | Sep 11, 2019 (2d) |
| Sep 4, 2019 | PGNX | ↑ Buy | 521,038 | $4.45 | $2.3M | Direct | Sep 5, 2019 (1d) |
| Aug 26, 2019 | PGNX | ↑ Buy | 204,056 | $4.31 | $879K | Direct | Aug 27, 2019 (1d) |
| Nov 13, 2014 | HZNP | ↓ Sell | 6,086,957 | $11.54 | $70.2M | By Altiva Capital, LLC | Nov 17, 2014 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Balaji Venkataraman's insider trades
Balaji Venkataraman is a 10% owner of Jasper Therapeutics (JSPR). Since Nov 13, 2014, Balaji has reported 4 open-market purchases worth $8.1M and 1 sale worth $70.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include shares returned to the company (2 filings), grants and awards (1 filing), conversions (1 filing), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every JSPR insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.